Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Success of Allergan integration is the human capital, says Teva

"People are the essence of the company going forward," said Teva, referring to the news that the world's largest generic drug maker will purchase Allergan's generics business for $40.5bn, at its Q2 financial results press conference on Thursday.

Afrezza sales stand at €5m since launch in February

FDA veteran questions science behind antibiotics fast track

As the US regulator awards iclaprim expedited QIDP status, a former FDA antibiotics expert says the scheme boosts antibiotics without enough evidence for efficacy.

News in brief

MannKind ups Afrezza production but Sanofi says sales are modest

MannKind has announced it has opened two extra production lines for inhalable insulin powder Afrezza, its joint venture with Sanofi.

Echo's cannabis API delivery formulation could aid low solubility drugs

A drug delivery platform which increased the bioavailability of a cannabis-based drug candidate 30% could be used to boost solubility of other APIs, says Echo Pharmaceuticals.

Sanofi Q2 Afrezza sales far from a giant leap for MannKind

The €3m Afrezza has contributed to Sanofi’s revenues since launch is unlikely to subdue growing concerns from commentators surrounding its partner MannKind which developed the inhalable insulin.

Drugs stolen while trucker changed his clothes recovered thanks to hidden GPS

A shipment of drugs stolen while a truck driver went home to change his clothes were recovered in half an hour thanks to a GPS tracking device embedded in the cargo.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...